Biallelic MAD2L1BP (p31comet) mutation is associated with mosaic aneuploidy and juvenile granulosa cell tumors.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
22 Nov 2023
Historique:
received: 27 02 2023
accepted: 02 10 2023
medline: 23 11 2023
pubmed: 5 10 2023
entrez: 5 10 2023
Statut: epublish

Résumé

MAD2L1BP-encoded p31comet mediates Trip13-dependent disassembly of Mad2- and Rev7-containing complexes and, through this antagonism, promotes timely spindle assembly checkpoint (SAC) silencing, faithful chromosome segregation, insulin signaling, and homology-directed repair (HDR) of DNA double-strand breaks. We identified a homozygous MAD2L1BP nonsense variant, R253*, in 2 siblings with microcephaly, epileptic encephalopathy, and juvenile granulosa cell tumors of ovary and testis. Patient-derived cells exhibited high-grade mosaic variegated aneuploidy, slowed-down proliferation, and instability of truncated p31comet mRNA and protein. Corresponding recombinant p31comet was defective in Trip13, Mad2, and Rev7 binding and unable to support SAC silencing or HDR. Furthermore, C-terminal truncation abrogated an identified interaction of p31comet with tp53. Another homozygous truncation, R227*, detected in an early-deceased patient with low-level aneuploidy, severe epileptic encephalopathy, and frequent blood glucose elevations, likely corresponds to complete loss of function, as in Mad2l1bp-/- mice. Thus, human mutations of p31comet are linked to aneuploidy and tumor predisposition.

Identifiants

pubmed: 37796616
pii: 170079
doi: 10.1172/jci.insight.170079
doi:
pii:

Substances chimiques

Mad2 Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Ghada M H Abdel-Salam (GMH)

Department of Clinical Genetics, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.

Susanne Hellmuth (S)

Chair of Genetics, University of Bayreuth, Bayreuth, Germany.

Elise Gradhand (E)

Senckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt, Germany.

Stephan Käseberg (S)

Institute of Human Genetics, University Medical Center Mainz, Mainz, Germany.

Jennifer Winter (J)

Institute of Human Genetics, University Medical Center Mainz, Mainz, Germany.

Ann-Sophie Pabst (AS)

Institute of Human Genetics, University Medical Center Mainz, Mainz, Germany.

Maha M Eid (MM)

Human Cytogenetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.

Holger Thiele (H)

Cologne Center for Genomics and.

Peter Nürnberg (P)

Cologne Center for Genomics and.
Center for Molecular Medicine Cologne, University Hospital of Cologne, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Birgit S Budde (BS)

Cologne Center for Genomics and.

Mohammad Reza Toliat (MR)

Cologne Center for Genomics and.

Ines B Brecht (IB)

Paediatric Haematology/Oncology, Department of Paediatrics, University Hospital Tübingen, Tübingen, Germany.

Christopher Schroeder (C)

Institute of Medical Genetics and Applied Genomics, Eberhard-Karls University, Tübingen, Germany.

Axel Gschwind (A)

Institute of Medical Genetics and Applied Genomics, Eberhard-Karls University, Tübingen, Germany.

Stephan Ossowski (S)

Institute of Medical Genetics and Applied Genomics, Eberhard-Karls University, Tübingen, Germany.

Friederike Häuser (F)

Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Mainz, Germany.

Heidi Rossmann (H)

Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Mainz, Germany.

Mohamed S Abdel-Hamid (MS)

Medical Molecular Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.

Ibrahim Hegazy (I)

Department of Clinical Genetics, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.

Ahmed G Mohamed (AG)

Pediatrics Department, Faculty of Medicine, Cairo University, Cairo, Egypt.

Dominik T Schneider (DT)

Clinic of Pediatrics, University Witten/Herdecke, Dortmund, Germany.

Aida Bertoli-Avella (A)

CENTOGENE GmbH, Rostock, Germany.

Peter Bauer (P)

CENTOGENE GmbH, Rostock, Germany.

Jillian N Pearring (JN)

Department of Ophthalmology and Visual Sciences and.
Department of Cell and Developmental Biology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.

Rolph Pfundt (R)

Department of Human Genetics and Radboud Institute for Molecular Life Sciences and.

Alexander Hoischen (A)

Department of Human Genetics and Radboud Institute for Molecular Life Sciences and.
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.

Christian Gilissen (C)

Department of Human Genetics and Radboud Institute for Molecular Life Sciences and.

Dennis Strand (D)

Department of Internal Medicine I, University Medical Center Mainz, Mainz, Germany.

Ulrich Zechner (U)

Institute of Human Genetics, University Medical Center Mainz, Mainz, Germany.
Senckenberg Centre for Human Genetics, Frankfurt am Main, Germany.

Soha A Tashkandi (SA)

Cytogenetics Laboratory, Pathology and Clinical Laboratory Medicine Administration (PCLMA), King Fahad Medical City, Second Central Healthcare Cluster (C2), Riyadh, Saudi Arabia.

Eissa A Faqeih (EA)

Section of Medical Genetics, Children's Specialist Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.

Olaf Stemmann (O)

Chair of Genetics, University of Bayreuth, Bayreuth, Germany.

Susanne Strand (S)

Department of Internal Medicine I, University Medical Center Mainz, Mainz, Germany.

Hanno J Bolz (HJ)

Senckenberg Centre for Human Genetics, Frankfurt am Main, Germany.
Institute of Human Genetics, University Hospital of Cologne, University of Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH